Skip to content
healthcare.dev

Anubis Barcelona

NDC 83021-546, DMAE, concentrate, from ANUBIS COSMETICS SL.

Product NDC
83021-546
Status
Listed
Labeler
ANUBIS COSMETICS SL
Dosage form
CONCENTRATE
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83021-546 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCERIN.555 g/30mL
  • PHENOXYETHANOL.243 g/30mL
  • XANTHAN GUM.09 g/30mL
  • FRAGRANCE 13576.027 g/30mL
  • SORBITAN ISOSTEARATE.024 g/30mL
  • HYDROLYZED BOVINE ELASTIN (BASE.0012 g/30mL
  • 1000 MW).0009 g/30mL
  • LIMONENE, (+)-.0003 g/30mL
  • TOCOPHEROL.0006 g/30mL
  • HYDROXYCITRONELLAL.024 g/30mL
  • POLYSORBATE 60.45 g/30mL
  • LECITHIN, SOYBEAN.405 g/30mL
  • HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (100000 MPA.S AT 1.5%).021 g/30mL
  • DEHYDROACETIC ACID1.08 g/30mL
  • PROPANEDIOL.9 g/30mL
  • DICAPRYLYL ETHER.036 g/30mL
  • BENZOIC ACID.15 g/30mL
  • ASCORBYL GLUCOSIDE25.5564 mL/30mL
  • WATER

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Nitrogen Binding Agent [EPC]; Non-Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
83021-546-308302105463030 mL in 1 BOTTLE, DROPPER (83021-546-30)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83021-546 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83021-546 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83021-546. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.